New York, NY, United States of America

Leonard Liebes



Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • New Rochelle, NY (US) (2010)
  • Brewster, NY (US) (2014)
  • New York, NY (US) (2012 - 2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Leonard Liebes: Innovator in Cancer Treatment

Introduction

Leonard Liebes is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment, holding a total of 4 patents. His innovative approaches focus on utilizing benzoic acid derivatives to enhance cancer therapies.

Latest Patents

Liebes' latest patents include a method for treating cancer using benzoic acid derivatives. This invention provides a method of treating cancer either alone or in combination with standard treatments such as chemotherapy and radiotherapy. Additionally, he has developed methods for screening benzoic derivatives based on their ability to inhibit the enzyme tyrosinase or to bind to and activate PXR/SXR xenobiotic receptors. Another significant patent involves the treatment of cancer using the sodium salt of a benzoic acid derivative, again in conjunction with standard treatments.

Career Highlights

Throughout his career, Leonard Liebes has worked with prestigious institutions such as New York University and Maine Medical Center. His work has been instrumental in advancing cancer treatment methodologies.

Collaborations

Liebes has collaborated with notable colleagues, including Peter C Brooks and Danielle Morais. Their combined expertise has contributed to the development of innovative cancer treatment strategies.

Conclusion

Leonard Liebes stands out as an influential inventor in the realm of cancer treatment, with a focus on benzoic acid derivatives. His contributions continue to impact the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…